Methods and pharmaceutical compositions for the treatment of beta-thalassemias
US9861615B2 · kind B2 · utility
0Cited by
0References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 28, 2014 |
| Grant date | Jan 9, 2018 |
| Priority date | — |
| Expiry date | Nov 28, 2034 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods and pharmaceutical compositions for the treatment of beta-thalassemias. In particular, the present invention relates to an XPO1 inhibitor for use in a method for treating beta-thalassemia in a subject in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.